Back to MDCEView Full LandscapeView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
5 competitors in Sickle Cell Disease
AGIOTebapivat
VRTXCasgevy
Phase 3AGIOMitapivat
Phase 3BEAMBEAM-101
Phase 2AGIOTebapivat Matched Placebo
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Low-dose PPI (Rabeprazole sodium)Phase 3
Cardio-cerebrovascular Disease
Ferric carboxymaltosePhase 3
Iron-deficiency
low-dose sucroferric oxyhydroxidePhase 2
Endstage Renal Disease
Alpha, gamma, beta, and delta (mixed) tocopherolsPhase 2
End-stage Renal Disease
Antispike gel, 100 g in a flask, produced by UNITEHPROM BSU, Republic of BelarusPhase 2
Abdominal Adhesions
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts